Dernière mise à jour :
Stabilité et compatibilité des médicaments
Bienvenue dans Stabilis.
Si vous désirez recevoir la newsletter trimestrielle, indiquez votre adresse email.

Pour toute question ou remarque, contactez :
Base de données  
Références bibliographies : 2138
Molécules : 765
Classes pharmacologiques : 40
Stabilités en solution : 4717
Stabilités en mélange : 1004
Incompatibilités : 2913
Noms commerciaux : 1964
Nouveautés - Molécules  
Antiviral Aérosol Ribavirine 03/03/2017
Anticancéreux Injectable Necitumumab 31/01/2017
Divers Injectable Belimumab 24/01/2017
Hypoglycémiant Injectable Insulin glulisine 24/01/2017
Divers Injectable Zoledronic acid 24/01/2017
Antidote Injectable Hydroxocobalamin 24/01/2017
Divers Injectable Trimebutine 24/01/2017
Divers Injectable Indocyanine green 24/01/2017
Stimulant respiratoire Solution buvable Caffeine 23/01/2017
Antiinflammatoire Solution buvable Naproxen 22/01/2017
Antidépresseur Solution buvable Sertraline hydrochloride 22/01/2017
Antiémétique Solution buvable Domperidone 22/01/2017
Antiépileptique Solution buvable Carbamazepine 22/01/2017
Divers Solution buvable Allopurinol 22/01/2017
Antidépresseur Solution buvable Clomipramine 22/01/2017
Antiarythmique Solution buvable Nadolol 22/01/2017
Antibiotique Solution buvable Clindamycine hydrochloride 11/01/2017
Inhibiteur de la pompe à proton Solution buvable Esomeprazole magnesium trihydrate 11/01/2017
Divers Injectable Plerixafor 28/11/2016
Hypoglycémiant Solution buvable Glibenclamide 18/11/2016
Nouveautés - Références bibliographies  
Date de saisie
3946 Stability of Extemporaneously Compounded Tacrolimus in Glass Bottles and Plastic Syringes Can J Hosp Pharm 06/03/2017
3941 Nicardipine - Summary of Product Characteristics Concordia International 21/02/2017
3938 Necitumumab (Portrazza®) – Résumé des caractéristiques du produits Lilly S.A 31/01/2017
3937 Stability study of docetaxel solution (0.9% saline) using Non-PVC and PVC tubes for intravenous administration. Biomat Res 30/01/2017
3930 Indocyanine (Infracyanine®) - Résumé des caractéristiques du produit Serb laboratoire 24/01/2017
3931 Trimébutine (Débridat®) - Résumé des caractéristiques du produit Pfizer Laboratoire 24/01/2017
3932 Hydroxocobalamine (Cyanokit®) - Résumé des caractéristiques du produit Serb Laboratoire 24/01/2017
3933 Acide zolédronique - (Acide zoledronique Teva Pharma®) - Résumé des caractéristiques du produit Teva Laboratoire 24/01/2017
3934 Eptifibatide (Integrilin®) - Résumé des caractéristiques du produit GlaxoSmithKline Laboratoire 24/01/2017
3935 Insuline glulisine (Insulines Sanofi Apidra®) - Résumé des caractéristiques du produit Sanofi Laboratoire 24/01/2017
3936 Bélimumab (Benlysta®) – Résumé des caractéristiques du produits GlaxoSmithKline Laboratoire 24/01/2017
3923 Stability of sildenafil in combination with heparin and dopamine. Am J Health-Syst Pharm 05/01/2017
3924 One-month stability study of a biosimilar of infliximab (Remsima®) after dilution and storage at 4 C and 25 C. Ann Pharm Fr 05/01/2017
3925 Long-term stability of dexamethasone and alizapride or ondansetron in sodium chloride 0.9% polyolefin bag at 5±3 C. Ann Pharm Fr 05/01/2017
3922 Compatibility of meropenem with different commercial dialysis solutions. Perit Dial Int 01/01/2017
3921 Stability of extemporaneously prepared enalapril maleate suspensions in glass bottles and plastic syringes. Can J Hosp Pharm 26/12/2016
3917 Stability of Ribavirin for Inhalation Packaged in Syringes or Glass Vials when Stored Frozen, Refrigerated, and at Room Temperature. Int J Pharm Compound 12/12/2016
3918 Compatibility of epirubicin-loaded DC bead™ with different non-ionic contrast media. J Oncol Pharm Practice 12/12/2016
3913 Compatibility of proton pump inhibitors in a preservative-free suspending vehicle. EJHP 03/12/2016
3910 Compatibility of caffeine, carvedilol, clomipramine hydrochloride, folic acid, hydrochlorothiazide, loperamide hydrochloride, methotrexate, nadolol, naltrexone hydrochloride and pentoxifylline in SyrSpend SF PH4 oral suspensions. EJHP 31/10/2016
3911 Does an interaction exist between ketamine hydrochloride and Becton Dickinson syringes? EJHP 31/10/2016
3901 Stability of Clindamycin Hydrochloride in PCCA Base SuspendIt Int J Pharm Compound 06/10/2016
3902 Stability of Allopurinol, Amitriptyline Hydrochloride, Carbamazepine, Domperidone, Isoniazid, Ketoconazole, Lisinopril, Naproxen, Paracetamol (Acetaminophen), and Sertraline Hydrochloride in SyrSpend SF PH4 Oral Suspensions. Int J Pharm Compound 06/10/2016
3903 Stability of Sodium Nitroprusside in 5% Dextrose Stored at 4°C in Polypropylene Syringes Protected from Light. Int J Pharm Compound 06/10/2016
3895 Physicochemical Stability Study of Polymyxin B in Various Infusion Solutions for Administration to Critically Ill Patients Ann Pharmacotherapy 06/09/2016
3896 Physicochemical Stability of Mozobil® (Plerixafor) Solution for Injection in Glass Vials and Plastic Syringes over a Three-Month Storage Period Pharmaceutical Technology in Hospital Pharmacy 06/09/2016
3897 Stability of Reconstituted and Diluted Mitomycin C Solutions in Polypropylene Syringes and Glass Vials. Pharmaceutical Technology in Hospital Pharmacy 06/09/2016
3898 Chemical and microbiological stability studies of an aqueous solution of pravastatin sodium salt for drug therapy of the dysphagic patients EJHP 06/09/2016
3892 Stability of Hydrocortisone, Nifedipine, and Nitroglycerine Compounded Preparations for the Treatment of Anorectal Conditions Can J Hosp Pharm 31/08/2016
3893 Stability of Extemporaneously Compounded Amlodipine Besylate Oral Suspensions Can J Hosp Pharm 31/08/2016

Temps de calcul serveur : 114 millisecondes